Loading…

Long‐term outcomes of patients with limited‐stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era

Saved in:

Bibliographic Details
Published in:	British journal of haematology 2023-02, Vol.200 (4), p.524-527
Main Authors:	Qualls, David, Imber, Brandon S., Okwali, Michelle, Hamlin, Paul A., Kumar, Anita, Lahoud, Oscar B., Matasar, Matthew J., Noy, Ariela, Owens, Colette, Zelenetz, Andrew D., North, Victoria S., Schöder, Heiko, Dogan, Ahmet, Salles, Gilles, Yahalom, Joachim, Falchi, Lorenzo
Format:	Article
Language:	English
Subjects:	Antibodies, Monoclonal, Murine-Derived - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Combined Modality Therapy diffuse large B cell lymphoma Humans Lymphoma, Large B-Cell, Diffuse - drug therapy ocular adnexa orbit outcomes radiation Rituximab Rituximab - therapeutic use treatment
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!